Breteler MMB - Search Results

1

Epigenetic and integrative cross-omics analyses of cerebral white matter hyperintensities on MRI.

Yang Y, Knol MJ, Wang R, Mishra A, Liu D, Luciano M, Teumer A, Armstrong N, Bis JC, Jhun MA, Li S, Adams HHH, Aziz NA, Bastin ME, Bourgey M, Brody JA, Frenzel S, Gottesman RF, Hosten N, Hou L, Kardia SLR, Lohner V, Marquis P, Maniega SM, Satizabal CL, Sorond FA, Valdés Hernández MC, van Duijn CM, Vernooij MW, Wittfeld K, Yang Q, Zhao W, Boerwinkle E, Levy D, Deary IJ, Jiang J, Mather KA, Mosley TH, Psaty BM, Sachdev PS, Smith JA, Sotoodehnia N, DeCarli CS, Breteler MMB, Ikram MA, Grabe HJ, Wardlaw J, Longstreth WT, Launer LJ, Seshadri S, Debette S, Fornage M. Yang Y, et al. Among authors: breteler mmb. Brain. 2023 Feb 13;146(2):492-506. doi: 10.1093/brain/awac290. Brain. 2023. PMID: 35943854 Free PMC article.

2

Epidemiology of Alzheimer's disease.

Breteler MM, Claus JJ, van Duijn CM, Launer LJ, Hofman A. Breteler MM, et al. Epidemiol Rev. 1992;14:59-82. doi: 10.1093/oxfordjournals.epirev.a036092. Epidemiol Rev. 1992. PMID: 1289117 Review. No abstract available.

3

Epidemiologic approach to the study of dementing diseases: a nested case-control study in European incidence studies of dementia.

Launer LJ, Brayne C, Breteler MM. Launer LJ, et al. Neuroepidemiology. 1992;11 Suppl 1:114-8. doi: 10.1159/000111005. Neuroepidemiology. 1992. PMID: 1603240

4

Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group.

Breteler MM, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, et al. Breteler MM, et al. Int J Epidemiol. 1991;20 Suppl 2:S36-42. doi: 10.1093/ije/20.supplement_2.s36. Int J Epidemiol. 1991. PMID: 1833352

5

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study.

Andersen K, Launer LJ, Ott A, Hoes AW, Breteler MM, Hofman A. Andersen K, et al. Neurology. 1995 Aug;45(8):1441-5. doi: 10.1212/wnl.45.8.1441. Neurology. 1995. PMID: 7644037

6

Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.

Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, van Harskamp F, Tanghe HL, de Jong PT, van Gijn J, et al. Breteler MM, et al. Neurology. 1994 Jul;44(7):1246-52. doi: 10.1212/wnl.44.7.1246. Neurology. 1994. PMID: 8035924

7

Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study.

Jama JW, Launer LJ, Witteman JC, den Breeijen JH, Breteler MM, Grobbee DE, Hofman A. Jama JW, et al. Am J Epidemiol. 1996 Aug 1;144(3):275-80. doi: 10.1093/oxfordjournals.aje.a008922. Am J Epidemiol. 1996. PMID: 8686696

8

Dietary antioxidants and Parkinson disease. The Rotterdam Study.

de Rijk MC, Breteler MM, den Breeijen JH, Launer LJ, Grobbee DE, van der Meché FG, Hofman A. de Rijk MC, et al. Arch Neurol. 1997 Jun;54(6):762-5. doi: 10.1001/archneur.1997.00550180070015. Arch Neurol. 1997. PMID: 9193212

9

Histamine H2 blocking drugs and the risk for Alzheimer's disease: the Rotterdam Study.

Launer LJ, Jama JW, Ott A, Breteler MM, Hoes AW, Hofman A. Launer LJ, et al. Neurobiol Aging. 1997 Mar-Apr;18(2):257-9. doi: 10.1016/s0197-4580(97)00010-9. Neurobiol Aging. 1997. PMID: 9258905 Clinical Trial.

10

Dietary fat intake and the risk of incident dementia in the Rotterdam Study.

Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM. Kalmijn S, et al. Ann Neurol. 1997 Nov;42(5):776-82. doi: 10.1002/ana.410420514. Ann Neurol. 1997. PMID: 9392577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

494 results

Search Page